Frontiers in Oncology | Thoracic Oncology

Systematic Review

Published on 15 Jul 2021

Postoperative Radiotherapy for Patients With Resectable Stage III-N2 Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

in Thoracic Oncology

Tianyu Lei
Jing Li
Hao Zhong
Huibo Zhang
Yan Jin
Jie Wu
Lan Li
Bin Xu
Qibin Song
Qinyong Hu

Frontiers in Oncology

doi 10.3389/fonc.2021.680615

6,456 views
16 citations

Systematic Review

Published on 14 Jul 2021

Consideration of Surrogate Endpoints for Overall Survival Associated With First-Line Immunotherapy in Extensive-Stage Small Cell Lung Cancer

in Thoracic Oncology

Shuang Zhang
Shuang Li
Yanan Cui
Peiyan Zhao
Xiaodan Sun
Ying Cheng

Frontiers in Oncology

doi 10.3389/fonc.2021.696010

4,428 views
9 citations

Original Research

Published on 12 Jul 2021

A Multicenter Retrospective Study on the Prognosis of Stage III Unresectable Mutant Non-Small Cell Lung Cancer With Tyrosine Kinase Inhibitors Therapy

in Thoracic Oncology

Ranpu Wu
Shaorong Yu
Jinjun Ye
Yimin Wang
Zhiting Zhao
Hongbing Liu
Yong Song

Frontiers in Oncology

doi 10.3389/fonc.2021.692703

3,692 views
9 citations

Original Research

Published on 09 Jul 2021

Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb Studies

in Thoracic Oncology

Antonio Passaro
Filippo de Marinis
Hai-Yan Tu
Konstantin K. Laktionov
Jifeng Feng
Artem Poltoratskiy
Jun Zhao
Eng Huat Tan
Maya Gottfried
Victor Lee

Frontiers in Oncology

doi 10.3389/fonc.2021.709877

7,362 views
14 citations

Review

Published on 09 Jul 2021

A Network Meta-Analysis of Cancer Immunotherapies Versus Chemotherapy for First-Line Treatment of Patients With Non-Small Cell Lung Cancer and High Programmed Death-Ligand 1 Expression

in Thoracic Oncology

Roy Herbst
Jacek Jassem
Seye Abogunrin
Daniel James
Rachael McCool
Rossella Belleli
Giuseppe Giaccone
Filippo De Marinis

Frontiers in Oncology

doi 10.3389/fonc.2021.676732

22,529 views
23 citations

Original Research

Published on 08 Jul 2021

Comprehensive Dissection of Treatment Patterns and Outcome for Patients With Metastatic Large-Cell Neuroendocrine Lung Carcinoma

in Thoracic Oncology

David Fisch
Farastuk Bozorgmehr
Daniel Kazdal
Jonas Kuon
Laura V. Klotz
Rajiv Shah
Florian Eichhorn
Mark Kriegsmann
Marc A. Schneider
Thomas Muley

Frontiers in Oncology

doi 10.3389/fonc.2021.673901

4,383 views
17 citations

Original Research

Published on 08 Jul 2021

Frequent Genetic Alterations and Their Clinical Significance in Patients With Thymic Epithelial Tumors

in Thoracic Oncology

Song Xu
Xiongfei Li
Hongyi Zhang
Lingling Zu
Lingqi Yang
Tao Shi
Shuai Zhu
Xi Lei
Zuoqing Song
Jun Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.667148

5,507 views
11 citations

Review

Published on 07 Jul 2021

Diagnosis and Molecular Profiles of Large Cell Neuroendocrine Carcinoma With Potential Targets for Therapy

in Thoracic Oncology

Helmut Popper
Luka Brcic

Frontiers in Oncology

doi 10.3389/fonc.2021.655752

5,804 views
12 citations

Original Research

Published on 07 Jul 2021

Genetic Variations in the Transforming Growth Factor-β1 Pathway May Improve Predictive Power for Overall Survival in Non-small Cell Lung Cancer

in Thoracic Oncology

Hong Zhang
Weili Wang
Wenhu Pi
Nan Bi
Colleen DesRosiers
Fengchong Kong
Monica Cheng
Li Yang
Tim Lautenschlaeger
Shruti Jolly

Frontiers in Oncology

doi 10.3389/fonc.2021.599719

4,409 views
6 citations

Review

Published on 06 Jul 2021

Circular RNAs in Lung Cancer: Recent Advances and Future Perspectives

in Thoracic Oncology

Huan-Huan Chen
Tie-Ning Zhang
Qi-Jun Wu
Xin-Mei Huang
Yu-Hong Zhao

Frontiers in Oncology

doi 10.3389/fonc.2021.664290

8,937 views
38 citations

Original Research

Published on 06 Jul 2021

Pulmonary Functional Imaging for Lung Adenocarcinoma: Combined MRI Assessment Based on IVIM-DWI and OE-UTE-MRI

in Thoracic Oncology

Hui Liu
Liyun Zheng
Gaofeng Shi
Qian Xu
Qi Wang
Hongshan Zhu
Hui Feng
Lijia Wang
Ning Zhang
Meng Xue

Frontiers in Oncology

doi 10.3389/fonc.2021.677942

4,209 views
8 citations

Original Research

Published on 01 Jul 2021

Solitary Fibrous Tumors of the Chest: An Analysis of Fifty Patients

in Thoracic Oncology

Jingwen Zhang
Jumin Liu
Zhihao Zhang
Beizong Tian

Frontiers in Oncology

doi 10.3389/fonc.2021.697156

5,871 views
18 citations

Original Research

Published on 29 Jun 2021

Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer

in Thoracic Oncology

Lea Daniello
Mariam Elshiaty
Farastuk Bozorgmehr
Jonas Kuon
Daniel Kazdal
Hannah Schindler
Rajiv Shah
Anna-Lena Volckmar
Fabienne Lusky
Leonore Diekmann

Frontiers in Oncology

doi 10.3389/fonc.2021.703893

10,024 views
60 citations

Mini Review

Published on 29 Jun 2021

P2X Receptors: Potential Therapeutic Targets for Symptoms Associated With Lung Cancer — A Mini Review

in Thoracic Oncology

Yonglin Mai
Zhihua Guo
Weiqiang Yin
Nanshan Zhong
Peter V. Dicpinigaitis
Ruchong Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.691956

7,600 views
17 citations

Original Research

Published on 29 Jun 2021

First-Line Chemo-Immunotherapy for Extensive-Stage Small-Cell Lung Cancer: A United States-Based Cost-Effectiveness Analysis

in Thoracic Oncology

Qiao Liu
Xia Luo
Lidan Yi
Xiaohui Zeng
Chongqing Tan

Frontiers in Oncology

doi 10.3389/fonc.2021.699781

8,206 views
34 citations

Original Research

Published on 28 Jun 2021

Pembrolizumab Alone or Combined With Chemotherapy in Advanced NSCLC With PD-L1 ≥50%: Results of a Retrospective Study

in Thoracic Oncology

Ya Chen
Yanan Wang
Zhengyu Yang
Minjuan Hu
Yanwei Zhang
Fangfei Qian
Wei Zhang
Bo Zhang
Baohui Han

Frontiers in Oncology

doi 10.3389/fonc.2021.691519

9,200 views
12 citations

Original Research

Published on 28 Jun 2021

How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center

in Thoracic Oncology

Giulia Pasello
Jessica Menis
Sara Pilotto
Stefano Frega
Lorenzo Belluomini
Federica Pezzuto
Anna Caliò
Matteo Sepulcri
Nunzia Luna Valentina Cernusco
Marco Schiavon

Frontiers in Oncology

doi 10.3389/fonc.2021.669786

4,054 views
11 citations

Systematic Review

Published on 25 Jun 2021

The Effect of Asymptomatic and/or Treated Brain Metastases on Efficacy of Immune Checkpoint Inhibitors in Metastatic Non–Small Cell Lung Cancer: A Meta-Analysis

in Thoracic Oncology

Sihan Li
Hongwei Zhang
Tingting Liu
Jun Chen
Jun Dang

Frontiers in Oncology

doi 10.3389/fonc.2021.702924

4,439 views
7 citations

Original Research

Published on 25 Jun 2021

Survival, Chemotherapy and Chemosensitivity Predicted by CTC Cultured In Vitro of SCLC Patients

in Thoracic Oncology

Lixia Ju
Juan Yang
Changyun Zhai
Shuizhen Chai
Zhiyi Dong
Minghua Li

Frontiers in Oncology

doi 10.3389/fonc.2021.683318

3,566 views
14 citations

Systematic Review

Published on 24 Jun 2021

Evaluation of the Lung Immune Prognostic Index in Non-Small Cell Lung Cancer Patients Treated With Systemic Therapy: A Retrospective Study and Meta-Analysis

in Thoracic Oncology

Litang Huang
Hedong Han
Li Zhou
Xi Chen
Qiuli Xu
Jingyuan Xie
Ping Zhan
Si Chen
Tangfeng Lv
Yong Song

Frontiers in Oncology

doi 10.3389/fonc.2021.670230

6,384 views
19 citations

Mini Review

Published on 24 Jun 2021

Homozygous Co-Deletion of Type I Interferons and CDKN2A Genes in Thoracic Cancers: Potential Consequences for Therapy

in Thoracic Oncology

Marion Grard
Camille Chatelain
Tiphaine Delaunay
Elvire Pons-Tostivint
Jaafar Bennouna
Jean-François Fonteneau

Frontiers in Oncology

doi 10.3389/fonc.2021.695770

6,650 views
15 citations

Original Research

Published on 24 Jun 2021

Clinical Relevance of PD-L1 Expression and CD8+ T Cells’ Infiltration in Patients With Lung Invasive Mucinous Adenocarcinoma

in Thoracic Oncology

Xiaoling Xu
Na Li
Ding Wang
Wei Chen
Yun Fan

Frontiers in Oncology

doi 10.3389/fonc.2021.683432

5,545 views
19 citations

Original Research

Published on 23 Jun 2021

Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma

in Thoracic Oncology

Lu Lu
Le-Ping Liu
Qiang-Qiang Zhao
Rong Gui
Qin-Yu Zhao

Frontiers in Oncology

doi 10.3389/fonc.2021.675545

15,948 views
83 citations

Original Research

Published on 23 Jun 2021

First-Line Treatment Options for PD-L1–Negative Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis

in Thoracic Oncology

Ling Peng
Wen-Hua Liang
De-Guang Mu
Song Xu
Shao-Dong Hong
Justin Stebbing
Fei Liang
Yang Xia

Frontiers in Oncology

doi 10.3389/fonc.2021.657545

30,761 views
19 citations

1,971 articles

articles

Postoperative Radiotherapy for Patients With Resectable Stage III-N2 Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

Consideration of Surrogate Endpoints for Overall Survival Associated With First-Line Immunotherapy in Extensive-Stage Small Cell Lung Cancer

A Multicenter Retrospective Study on the Prognosis of Stage III Unresectable Mutant Non-Small Cell Lung Cancer With Tyrosine Kinase Inhibitors Therapy

Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb Studies

A Network Meta-Analysis of Cancer Immunotherapies Versus Chemotherapy for First-Line Treatment of Patients With Non-Small Cell Lung Cancer and High Programmed Death-Ligand 1 Expression

Comprehensive Dissection of Treatment Patterns and Outcome for Patients With Metastatic Large-Cell Neuroendocrine Lung Carcinoma

Frequent Genetic Alterations and Their Clinical Significance in Patients With Thymic Epithelial Tumors

Diagnosis and Molecular Profiles of Large Cell Neuroendocrine Carcinoma With Potential Targets for Therapy

Genetic Variations in the Transforming Growth Factor-β1 Pathway May Improve Predictive Power for Overall Survival in Non-small Cell Lung Cancer

Circular RNAs in Lung Cancer: Recent Advances and Future Perspectives

Pulmonary Functional Imaging for Lung Adenocarcinoma: Combined MRI Assessment Based on IVIM-DWI and OE-UTE-MRI

Solitary Fibrous Tumors of the Chest: An Analysis of Fifty Patients

Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer

P2X Receptors: Potential Therapeutic Targets for Symptoms Associated With Lung Cancer — A Mini Review

First-Line Chemo-Immunotherapy for Extensive-Stage Small-Cell Lung Cancer: A United States-Based Cost-Effectiveness Analysis

Pembrolizumab Alone or Combined With Chemotherapy in Advanced NSCLC With PD-L1 ≥50%: Results of a Retrospective Study

How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center

The Effect of Asymptomatic and/or Treated Brain Metastases on Efficacy of Immune Checkpoint Inhibitors in Metastatic Non–Small Cell Lung Cancer: A Meta-Analysis

Survival, Chemotherapy and Chemosensitivity Predicted by CTC Cultured In Vitro of SCLC Patients

Evaluation of the Lung Immune Prognostic Index in Non-Small Cell Lung Cancer Patients Treated With Systemic Therapy: A Retrospective Study and Meta-Analysis

Homozygous Co-Deletion of Type I Interferons and CDKN2A Genes in Thoracic Cancers: Potential Consequences for Therapy

Clinical Relevance of PD-L1 Expression and CD8+ T Cells’ Infiltration in Patients With Lung Invasive Mucinous Adenocarcinoma

Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma

First-Line Treatment Options for PD-L1–Negative Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis